![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mts Medication Technologies, | AMEX:MPP | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
_________________
_________________
MTS Medication Technologies, Inc. | ||
|
||
(Exact Name of registrant as specified in its charter) |
Delaware | 001-31578 | 59-2740462 | |||
|
|
|
|||
(State or other jurisdiction | (Commission File Number) | (IRS Employer | |||
of incorporation) | Identification No.) |
2003 Gandy Boulevard North, St. Petersburg, Florida | 33702 | |||
|
|
|||
(Address of Principal Executive Offices) | (Zip Code) |
727-576-6311 | ||
|
||
(Registrant's Telephone Number, Including Area Code) |
N/A | ||
|
||
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-42(c))
On July 2, 2008, MTS Medication Technologies, Inc. (MTS) issued a press release announcing that its Board of Directors has approved the listing of its common stock on The NASDAQ Stock Market LLC. On June 10, 2008, MTS received a letter from The NASDAQ Stock Market LLC approving MTS application to list its common stock on The NASDAQ Capital Market. On July 2, 2008, MTS provided The American Stock Exchange the required written notice of MTS intention to withdraw the listing of its common stock from The American Stock Exchange.
MTS expects that its common stock will begin trading on The NASDAQ Capital Market under the new symbol MTSI on July 15, 2008. MTS common stock will continue to trade on The American Stock Exchange under the current symbol MPP until such date.
A copy of the July 2, 2008 press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibit | Description | |||
99.1 | Press Release issued by MTS Medication Technologies, Inc. on July 2, 2008. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
MTS Medication Technologies, Inc. | |||||||||||
(Registrant) | |||||||||||
Date: July 2, 2008 | By: |
/s/ Michael P. Conroy
|
|||||||||
|
Michael P. Conroy | ||||||||||
Vice President and Chief Financial Officer |
2
1 Year Mts Medications Chart |
1 Month Mts Medications Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions